Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
2
×
addiction
anxiety
aura health
biotech
boston
boston blog main
boston top stories
cancer
cancer immunotherapy
center for medicare and medicaid services
column
companion diagnostic
daniel o'day
deals
depression
digital therapeutics
federal drug administration
foundation medicine
foundationone cdx
foundationone heme
funding
genentech
government
health
life sciences
mental health
national blog main
national top stories
new york blog main
osimertinib
pacifica
policy
roche
rucaparib (rubraca)
san francisco blog main
simple habit
startups
stress
tc
What
medicine
share
2
×
acquire
agreed
angel
applied
attorney
big
billion
broad
college
confidence
contributor
didn’t
digital
disorders
doctorate
foundation
gain
genentech
health
integrative
investor
madeline
mental
michael
momentum
morning
panels
pay
pays
picked
profiling
psychophysiology
recently
redux
remaining
rest
rewards
risks
Language
Current search:
share
×
fda
×
@techcrunch.com
4 years ago
Risks and rewards of digital therapeutics in treating mental disorders
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine